Gastric secretion regulation

Gastric Gland Cells - The Stomach's Crew

Secretion Phases - Thinking, Tasting, Digesting

Gastric secretion is regulated in three phases, aligning acid release with the presence of food. The initial phases are stimulatory, while the final phase is primarily inhibitory.

• Cephalic Phase: Triggered by thought, sight, or taste of food. Mediated entirely by the vagus nerve, accounting for ~30% of total secretion.
• Gastric Phase: Activated by food in the stomach (distension, peptides). Accounts for ~60% of secretion, driven by gastrin and vago-vagal reflexes.
• Intestinal Phase: Chyme entering the duodenum initiates inhibitory signals (Secretin, CCK) to ↓ acid.

⭐ The intestinal phase is crucial for negative feedback. Release of Secretin in response to duodenal acid ($H^+$) is the most potent inhibitor of gastrin release and gastric acid secretion.

Molecular Regulators - The Chemical Orchestra

• Stimulatory Pathways (↑ H⁺) 📌 Mnemonic: All Good Health (ACh, Gastrin, Histamine).

  • Acetylcholine (ACh): Released from vagal nerve endings.
    • Binds M3 receptors on parietal cells.
    • Pathway: $G_q \rightarrow \uparrow IP_3/Ca^{2+}$.
  • Gastrin: Secreted by G-cells in the antrum.
    • Binds CCK2 receptors on parietal and ECL cells.
    • Pathway: $G_q \rightarrow \uparrow IP_3/Ca^{2+}$.
    • Potently stimulates histamine release.
  • Histamine: Released from Enterochromaffin-like (ECL) cells.
    • Binds H2 receptors on parietal cells.
    • Pathway: $G_s \rightarrow \uparrow cAMP$.

• Inhibitory Pathways (↓ H⁺)

  • Somatostatin: Secreted by D-cells.
    • Acts via $G_i$ to ↓cAMP.
    • Inhibits G-cells, ECL cells, and parietal cells.
  • Prostaglandins (PGE₂):
    • Act via $G_i$ to ↓cAMP.
    • Cytoprotective: ↑ mucus and $HCO_3^-$ secretion.

⭐ Potentiation: Histamine potentiates the effects of gastrin and ACh. The combined effect of all three is greater than the sum of their individual effects, a key principle for drug action (e.g., H2 blockers).

Clinical Tie-ins - When Glands Go Rogue

• Zollinger-Ellison Syndrome (ZES): Caused by a gastrin-secreting tumor (gastrinoma), often in the pancreas or duodenum.
  • Leads to unrelenting acid production (↑↑ HCl), causing multiple, refractory, or unusually located (e.g., jejunal) peptic ulcers.
  • Presents with abdominal pain, chronic diarrhea (pancreatic enzyme inactivation), and heartburn.
  • Associated with Multiple Endocrine Neoplasia type 1 (📌 MEN1).
• Pernicious Anemia: Autoimmune gastritis targeting parietal cells.
  • Results in ↓ HCl (achlorhydria) and loss of intrinsic factor (IF).
  • IF deficiency causes vitamin B12 malabsorption, leading to megaloblastic anemia and neurological symptoms.
  • Achlorhydria stimulates G-cell hyperplasia, causing ↑ serum gastrin.

⭐ In ZES, a secretin stimulation test is diagnostic. Normally, secretin inhibits G-cell gastrin release, but it paradoxically stimulates gastrin release from a gastrinoma.

High-Yield Points - ⚡ Biggest Takeaways

• Vagal stimulation (ACh) is a key driver, directly acting on parietal cells and stimulating gastrin and histamine release.
• Gastrin from G cells potently stimulates acid, primarily by triggering histamine release from ECL cells.
• Histamine is the strongest direct stimulant of parietal cells via H2 receptors.
• Somatostatin from D cells is the universal inhibitory signal for parietal, G, and ECL cells.
• Low gastric pH (<3) stimulates somatostatin release, providing essential negative feedback.
• Prostaglandins are cytoprotective, inhibiting acid while stimulating mucus/bicarbonate secretion.